Cineplex accuses Cineworld of "buyer's remorse" and seeking to avoid its obligations under the merger agreement because of the COVID-19 pandemic.
The generic drugmaker listed $10 billion of debt and $10 billion of assets.
The apparent demise of Randa's $460 million proposal clears the way for Perry Ellis to be taken private by founder George Feldenkreis.
The Irish packaging firm says the revised proposal "does not make strategic sense" and would expose shareholders to "significantly greater leverage."
The $1.2 billion purchase of Stewart Information Services will strengthen Fidelity's position as the No. 1 title insurance underwriter in the U.S.
The companies will meet on Wednesday even though Qualcomm has rejected its rival's improved $121 billion takeover offer as inadequate.
The former accountant at Celator Pharmaceuticals allegedly passed on tips about market-moving announcements by the company to friends.
The merger between two of the largest outdoor gear retailers would add Cabela's 85 stores and "loyal following" to Bass Pro's system.
The retailer follows Alden Global's purchase of a 9.5% stake with a plan to protect shareholders from “coercive or unfair” tactics.
The deal continues the wave of consolidation in agribusiness, pairing Bayer's strength in crop chemicals with Monsanto's portfolio of seed products.
The $14 billion acquisition would add the best-selling prostate cancer drug Xtandi to Pfizer's growing oncology portfolio.
The $22.8 billion proposal would create the world's largest candy maker but the Hershey Trust may stand in the way of any suitor.
